All Insights

IT and data

The UK Data (Use and Access) Bill – what businesses should be aware of

The wide-ranging bill covers much more than changes to data protection rules
Life Sciences and Healthcare

England's health and social care sector can expect more change at the Care Quality Commission

Healthcare providers face uncertainty following the rollout of the single assessment framework amid public criticism
Regulatory and compliance

UK government launches the Regulatory Innovation Office

RIO will support innovative businesses in fast-growth sectors by speeding up regulatory approval and cutting 'red tape'
Life Sciences and Healthcare

European Medicines Agency issues guidance on AI use in pharma regulatory science

The drug agency's new guidance focuses on regulatory authorities but holds relevance for the industry
Life Sciences and Healthcare

Belgium advances digital health as its Parliament calls for action

The government has been urged to prioritise accessible and affordable digital health solutions
Life Sciences and Healthcare

Draghi report on EU competitiveness offers new recommendations for pharma and biotech

The former European central banker's report delivers strategic insights for pharma companies doing business in the EU
Life Sciences and Healthcare

EU competitiveness report pushes for greener and digitalised medical and IVD

The Draghi report warns of the major impact on medical device firms from digitalisation and heavy regulation
Artificial intelligence

House of Lords sets the tone on regulation of automated decision-making in the UK public sector

Companies hoping to sell AI systems to public authorities should monitor the progress of a new private members' bill
Regulatory and compliance

New UK public procurement regime delayed to February 2025

The government has pushed the implementation of the Procurement Act 2023 back by four months
Regulatory and compliance

How 'known risks' will work under the UK Procurement Act 2023

What should be considered when dealing with the list of known risks in a tender notice?